BI 113823
Sponsors
Boehringer Ingelheim
Conditions
HealthyOsteoarthritis
Phase 1
Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823
CompletedNCT01189175
Start: 2010-08-31Updated: 2013-11-01
Safety, Tolerability, Pharmacokinetics and -Dynamics of Multiple Rising Oral Doses of BI 113823 in Patients Patients With Osteoarthritis of the Knee
TerminatedNCT01207973
Start: 2010-09-30Updated: 2013-11-05